Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Fmr LLC

Fmr LLC cut its stake in shares of Azenta, Inc. (NASDAQ:AZTA) by 9.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 6,391 shares of the company’s stock after selling 676 shares during the period. Fmr LLC’s holdings in Azenta were worth $310,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Hantz Financial Services Inc. acquired a new position in Azenta in the second quarter valued at $30,000. Farther Finance Advisors LLC raised its holdings in shares of Azenta by 20.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock worth $74,000 after purchasing an additional 256 shares during the period. Benjamin F. Edwards & Company Inc. lifted its stake in shares of Azenta by 150.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock valued at $84,000 after purchasing an additional 955 shares in the last quarter. Net Worth Advisory Group purchased a new stake in shares of Azenta during the 3rd quarter worth about $205,000. Finally, Aigen Investment Management LP acquired a new stake in Azenta during the 3rd quarter worth approximately $214,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

AZTA has been the topic of a number of recent research reports. Stephens raised shares of Azenta from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $50.00 to $60.00 in a research report on Wednesday. Needham & Company LLC cut their target price on shares of Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Finally, Evercore ISI decreased their price target on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a research report on Tuesday, October 1st. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, Azenta has a consensus rating of “Moderate Buy” and a consensus target price of $61.60.

Azenta Stock Up 1.9 %

NASDAQ AZTA opened at $50.43 on Friday. Azenta, Inc. has a fifty-two week low of $38.82 and a fifty-two week high of $69.16. The business has a 50 day moving average price of $44.69 and a two-hundred day moving average price of $49.45. The stock has a market cap of $2.30 billion, a PE ratio of -16.98 and a beta of 1.49.

Azenta (NASDAQ:AZTA) last announced its earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.08. The business had revenue of $170.00 million during the quarter, compared to the consensus estimate of $169.66 million. Azenta had a negative net margin of 25.01% and a positive return on equity of 1.03%. The business’s quarterly revenue was down 1.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.13 earnings per share. Sell-side analysts anticipate that Azenta, Inc. will post 0.41 EPS for the current fiscal year.

Insider Buying and Selling at Azenta

In other news, CFO Herman Cueto sold 1,595 shares of the firm’s stock in a transaction that occurred on Thursday, October 17th. The shares were sold at an average price of $43.68, for a total transaction of $69,669.60. Following the completion of the sale, the chief financial officer now owns 24,604 shares of the company’s stock, valued at approximately $1,074,702.72. This trade represents a 6.09 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William L. Cornog purchased 12,500 shares of the business’s stock in a transaction that occurred on Monday, November 18th. The stock was bought at an average cost of $39.60 per share, for a total transaction of $495,000.00. Following the completion of the acquisition, the director now directly owns 14,755 shares of the company’s stock, valued at $584,298. This represents a 554.32 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold a total of 3,018 shares of company stock valued at $126,689 in the last ninety days. Insiders own 1.77% of the company’s stock.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.